Risk/benefit analysis for the use and approval of thrombolytic, antiarrhythmic, and hypolipidemic agents : proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988
書誌事項
- タイトル
- "Risk/benefit analysis for the use and approval of thrombolytic, antiarrhythmic, and hypolipidemic agents : proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988"
- 責任表示
- edited by Joel Morganroth and E. Neil Moore
- 出版者
-
- Kluwer Academic Publishers
- 出版年月
-
- c1989
- 書籍サイズ
- 24 cm
この図書・雑誌をさがす
注記
Includes bibliographical references
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1130282270902278272
-
- NII書誌ID
- BA07429465
-
- ISBN
- 079230294X
-
- LCCN
- 89011044
-
- Web Site
- https://lccn.loc.gov/89011044
-
- 本文言語コード
- en
-
- 出版国コード
- us
-
- タイトル言語コード
- en
-
- 出版地
-
- Boston
-
- 件名
-
- LCSH: Fibrinolytic agents -- Effectiveness -- Congresses
- LCSH: Myocardial depressants -- Effectiveness -- Congresses
- LCSH: Antilipemic agents -- Effectiveness -- Congresses
- LCSH: Risk assessment -- Congresses
- MESH: Anti-Arrhythmia Agents -- therapeutic use -- congresses
- MESH: Antilipemic Agents -- therapeutic use -- congresses
- MESH: Fibrinolytic Agents -- therapeutic use -- congresses
-
- データソース種別
-
- CiNii Books